MFS Emerging Markets Debt C (MEDCX)
Nasdaq • Currently unchanged in today's trading session
1 member of Congress has disclosed 1 trade in MFS Emerging Markets Debt C (MEDCX) via STOCK Act filings. The most recent disclosure was a purchase by Brian Babin on 23 September 2019. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).
MFS Emerging Markets Debt C is currently trading at $12.69, positioned at 51% of its 52-week range ($12.39 – $12.98).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
MFS Emerging Markets Debt C Price History and Technical Analysis
Congressional Trading Activity for MEDCX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about MEDCX
- Which members of Congress have traded MEDCX?
- 1 member of Congress has disclosed 1 trade in MFS Emerging Markets Debt C (MEDCX) under the STOCK Act: Brian Babin.
- When was MEDCX most recently disclosed by Congress?
- The most recent MEDCX disclosure was a purchase by Brian Babin on 23 September 2019.
- What is the total disclosed congressional trading volume for MEDCX?
- Members of Congress have disclosed approximately $8K in MEDCX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in MEDCX?
- This MEDCX page updates as soon as new STOCK Act disclosures are filed for MFS Emerging Markets Debt C. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track MEDCX in Congress
See when politicians buy or sell this stock